NIH launches trial for rare degenerative muscle disease treatment
Researchers have launched a clinical trial to evaluate the drug candidate DEX-M74 as a treatment for a rare degenerative muscle disease, hereditary inclusion body myopathy (HIBM). National Institutes of Health scientists ...
Sep 24, 2012
0
0